This study compared the effects of (Ϯ)3,4-methylenedioxymethamphetamine, d-amphetamine, and cocaine on performance of rats in a delayed matching-to-sample procedure using a variety of indices of performance to determine the mechanism by which working memory task impairments arise. All 3 drugs produced an overall delay-independent decrease in accuracy rather than a delay-dependent increase in the rate of forgetting. This impairment arose as a result of current-trial choice responses being progressively more affected by responses made in the immediately preceding trial as drug dose increased. Therefore, all 3 drugs produced qualitatively similar disruptions in memory task performance best characterized as an impairment arising from proactive sources of interference.
There is considerable interest in the behavioral and cognitive effects produced by exposure to (Ϯ)3,4-methylenedioxymethamphetamine (MDMA). Several reviews have raised concerns about the negative effects that MDMA may have on human users across a wide range of basic processes, including sleeping, appetite control, impulsiveness, and mood (McGuire, 2000; Morgan, 2000; Parrott, 2001) . Such reviews have also highlighted the common finding that MDMA produces deficits in short-term or working memory function. For example, Parrott and Lasky (1998) found that while under the influence of MDMA, both inexperienced and regular MDMA users recalled 60%-70% fewer words in a recall task relative to people who had never used MDMA. Such deficits were more pronounced in the regular users but were still present in both MDMA groups 7 days after exposure to MDMA. Evidence for impairments in various memory tasks, including immediate and delayed recall of words and prose (Morgan, 2000; Zakzanis & Young, 2001) , Corsi Blocks memory span (Verkes et al., 2001) , prospective memory (Heffernan, Ling, & Scholey, 2001) , and various working memory tasks (Fox et al., 2002; Wareing, Fisk, & Murphy, 2000) , have also been reported.
For practical reasons, the human research has had to focus on the chronic effects of MDMA in occasional to regular users, who often use MDMA in conjunction with other drugs (Fox et al., 2002) . Therefore, little is known about the acute effects of MDMA on cognitive functions. One of the few exceptions is the study mentioned above by Parrott and Lasky (1998) , who found that acute exposure to MDMA produced impairments in word recall and visual search tasks. The verbal reports of participants in their study suggested that these impairments may have been related to general problems in attending to the relevant environmental events. Thus, one possibility suggested by the human acute data is that MDMA's effects on memory task performance may not be related to a problem with memory storage per se but are more a product of a general impairment in attentional processes. The current study examined the acute effects of MDMA in rats as a way to test this possibility experimentally using the delayed matching-to-sample (DMTS) task as an analogue of a human episodic recognition memory task.
A great deal of previous research has focused on the neurological and physiological effects of acute and chronic MDMA exposure in rats and mice (see Green, Mechan, Elliott, O'Shea, & Colado, 2003, for a review) . Consistent with the human literature, the animal literature has demonstrated changes in 5-hydroxytryptamine (5-HT) and dopamine function in the brain as well as a range of well-known effects on body temperature, cardiovascular activity, and motor control. However, there has been relatively little done to examine cognitive and memory effects of MDMA in rats, especially with respect to acute effects. One study by LeSage, Clark, and Poling (1993) found that acute administration of doses greater than 1.7 mg/kg to pigeons reduced accuracy at all delays in a DMTS task. In another study, Taffe et al. (2001) found that DMTS performance in rhesus monkeys was disrupted during a week in which they received twice-daily doses of 10 mg/kg MDMA. This disruption was best characterized as an overall lowering of accuracy across all delay intervals, which suggests an impairment of attentional processes as opposed to memory retention. However, Taffe et al. also found significant impairments in a motor task and progressive ratio performance, raising the possibility that DMTS performance was impaired indirectly by means of a disruption to motor function, reinforcer efficacy, or increased distractibility. Thus, although limited evi-dence suggests that acute administration of MDMA impairs memory task performance, many questions remain concerning the source and nature of this disruption.
MDMA's effects on memory task performance may be similar to those of d-amphetamine or cocaine because all three drugs act as fairly nonspecific dopamine agonists soon after administration (Bushnell & Levin, 1993; Green et al., 2003; Perlow, Chiueh, Lake, & Wyatt, 1980; Ushijima, Carino, & Horita, 1995) , but the effects may be dissimilar given that many of MDMA's behavioral effects have been linked to disruption in 5-HT activity, whether as an immediate increase in 5-HT release or as a long-term decrease in 5-HT activity as a result of neurotoxicity (Parrott, 2001; Verkes et al., 2001) . Therefore, there is reason to predict that there may be some similarity among MDMA, d-amphetamine, and cocaine in terms of their acute effects on memory task performance based on a shared ability to act as dopamine agonists. However, there are numerous differences between these drugs in terms of their effects on other transmitter systems (e.g., 5-HT) and the effects they may have on various behavioral processes that are likely to impact memory task performance (e.g., attentional, motivational, and motor processes). Thus, it is important to make a direct comparison across these three drugs using a task that can enable us to discriminate among memorial, attentional, motivational, and motor changes in performance.
The current experiment compared the effects of MDMA, d-amphetamine, and cocaine on a DMTS task using lever position as stimuli and rats as subjects to clarify behavioral and neurochemical mechanisms by which acute MDMA may produce an impairment on memory task performance. A major issue was to accurately characterize the effects of MDMA on DMTS performance in terms of the distinction made between attentional delayindependent changes in accuracy versus memory delay-dependent changes in accuracy (Harper, 2000; White, 1985) . If MDMA's effects on memory task performance are attributable to impaired attentional processing, then an overall delay-independent decrement in accuracy is expected. Another advantage of the DMTS task is that it enables a number of measures of performance such as response bias and response latency that may help elucidate the precise behavioral locus of any performance deficit. One analysis in particular that is useful in the present context is an assessment of the influence of previous trial responses on current trial accuracy. Sometimes referred to as an analysis of proactive interference (e.g., Dunnett & Martel, 1990; Edhouse & White, 1988) , this analysis typically reveals that subjects are more accurate on trials in which the choice response made in the immediately preceding trial was the same as the response required for a correct choice in the current trial (vs. when the previous response was different from that required in the current trial). It has previously been shown that as the intertrial interval decreases (i.e., trials become closer together), there is an overall decrease in accuracy that arises because of an increase in the impact of previous trial choice responses on current-trial choice (see Dunnett & Martel, 1990) . Although this influence is facilitative when the choice response made in the previous trial was to the same operandum associated with a correct choice in the current trial (e.g., a "left" response followed by another "left" response), accuracy is impaired when the choice response made in the previous trial was to the opposite operandum required for a correct choice on the current trial (e.g., a "right" response followed by a "left" response). Thus, an analysis of proactive interference can help elucidate the mechanism underlying a potential drug-induced impairment in accuracy.
Method

Subjects
Eighteen naive male Sprague-Dawley rats, approximately 3 months old at the start of training, were maintained at 85% of their free-feeding body weights (range ϭ 190 -250 g). Supplementary feed was given after each session to maintain prescribed body weights. Rats were housed in pairs; water and untreated wood shavings were available continuously in their home cages. The housing room was maintained at a constant 22°C with lights off between 7:00 a.m. and 7:00 p.m. All experimental procedures were performed between 8 a.m. and 5 p.m. 5 days per week. Laboratory animal care principles of the Victoria University of Wellington Animal Breeding Facility were followed, and the Victoria University of Wellington Animal Ethics Committee approved all protocols.
Apparatus
Rats were trained and tested in five standard response chambers, measuring approximately 31 cm long ϫ 31 cm wide ϫ 25 cm high. Retractable response levers were located on both the left and right sides of the front interface panel. A nonretractable lever was located in the middle of the opposite wall. An 80-mA red light was located immediately above all levers. Reinforcers (0.1 ml of a 1:14 mixture of sweetened milk and water) were delivered at floor level in the center of the front panel by means of a dipper mechanism. The chambers were located in a darkened room adjacent to the housing room. All experimental events were scheduled and recorded by an IBM-compatible computer running MED-PC software (MED Associates, East Fairfield, VT).
Behavioral Procedure
Each rat was assigned to a specific experimental chamber where it participated in all training and testing sessions. All sessions lasted 90 min and were conducted daily 5 days per week. Rats were gradually trained to respond on all three levers using standard shaping techniques. All rats performed the basic matching-to-sample task (described next) with no delay between stimulus presentation and choice at a level of 80% or above after a total of 58 training sessions. Once rats were performing the basic matching-to-sample task, the DMTS task was introduced by inserting four different delay durations between sample presentation and choice. DMTS trials comprised the following sequence of events:
1. Sample presentation. Either the left or right lever was inserted into the chamber and the corresponding light was illuminated.
Whether the left or right lever was inserted into the chamber was determined by a pseudorandom sequence, which allowed no more than four sequential presentations of a particular lever. Following three presses on the sample lever, it was retracted and the light above was extinguished.
2. Delay interval. The light above the rear lever was illuminated, and a variable delay period was initiated that ended with the first rear lever response after a predetermined time period had elapsed. The scheduled delays were 0.1, 3.0, 9.0, or 18.0 s. The delays for each trial type (i.e., left or right lever sample stimulus) were selected on a pseudorandom basis, which ensured that each duration was used equally often for each type of trial.
3. Choice. On completion of the delay, the rear light was turned off and both the left and right front levers were inserted into the chamber, with their associated lamps illuminated. As soon as a single response was made on either of the levers, the lights were extinguished and the levers were retracted. If the response made was to the lever that was inserted as the sample stimulus at the beginning of the trial (i.e., a correct matching-to-sample response), a reinforcer was delivered. If the response was made to the other lever, the response was counted as an error and was not reinforced. A trial was canceled if a rat took more than 20 s to make a choice response on delay termination.
4. Intertrial interval. After 2.5 s of dipper availability (following a correct response) or 2.5-s time-out (following an error response), a 5-s intertrial interval began during which the chamber was darkened. On completion of the intertrial interval, a new trial was initiated.
After a further 26 sessions of training in the DMTS task described previously, all rats were showing stable performance, and the effects of d-amphetamine, cocaine, and MDMA were tested as described below.
Pharmacological Procedure
Drugs were dissolved to the appropriate dose in 0.9% saline prior to administration. Injections were delivered via an intraperitoneal injection at a volume of 1 ml/kg approximately 10 min before a rat was placed in the response chamber. Injections were given on Tuesdays and Fridays. Five different doses were tested for each drug: 0.0, 0.1, 0.3, 0.6, and 1.0 mg/kg amphetamine; 0.0, 1.0, 3.0, 10.0, and 20.0 mg/kg cocaine; and 0.0, 0.3, 1.0, 2.0, and 3.0 mg/kg MDMA. Drug delivery was counterbalanced across all subjects so that each subject participated in all the drug and dose conditions across the experimental sessions. Rats were still trained in the DMTS task on nondrug delivery days.
Performance Measures
For individual subjects the total correct and error matching responses were obtained at each of the four delays in each drug-dose condition. Using these data, a number of measures of DMTS task performance were calculated. Two of these measures reflected performance accuracy: percent correct and the bias-free measure, log d. Although a common measure of accuracy, percent correct confounds errors made in recognizing the correct stimulus with errors that arise because of a response bias that arises from a nonmemorial preference to choose one stimulus over the other (Davison & Tustin, 1978) . Consequently, a number of studies have found it more informative to use an alternate bias-free measure of discriminability, such as log d, in addition to percent correct (for examples of the calculation and use of log d, see Harper, 2000; Harper, McLean & Dalrymple-Alford, 1994; Kirk, White, & McNaughton, 1988; Ruske, Harper, Colombo, & White, 1995; White, Ruske, & Colombo, 1996) . Another measure of DMTS performance obtained at each delay in the present study was response bias itself, log bias (Davison & Tustin, 1978) . Log bias measures the tendency to choose one choice stimulus over the other irrespective of discrimination performance.
Another advantage of using log d as a measure of accuracy is that there is considerable empirical evidence that this measure decreases in a negative exponential manner with increasing delay duration (White, 1985 (White, , 2001 . Thus, the reduction in log d across delays is well described by the following equation:
where log d t is the measure of accuracy at delay t, and the parameters log d 0 and b afford independent measures of remembering. Log d 0 (the y-intercept) describes overall delay-independent discriminability, and b (the slope of the function) describes the rate of forgetting. Factors affecting log d 0 are viewed as delay independent in that they contribute to the encoding of sample stimuli and involve attentional or perceptual processes.
The rate of forgetting, b, is affected by factors that interfere with retrieval and rehearsal mechanisms (see White, 1985 White, , 2001 ). To more precisely determine the factors leading to any accuracy changes identified using the analyses outlined above, trials were also analyzed separately depending on the response made in the immediately preceding trial. Specifically, accuracy at each delay was calculated on the basis of whether the response required on the current trial (i.e., the correct response option) was the same or different from the response made on the immediately previous trial. For example, if the choice response made on the preceding trial was to the left lever (irrespective of whether this choice was correct or not) and the response required (i.e., the correct response option) on the current trial was also left, then this current trial would be coded as a same trial. If, however, the choice response on the preceding trial was to the right lever, then the current trial would be coded as a different trial.
Two other measures related to the motor aspects of DMTS performance were also collected: number of trials completed in a session and response latency. Response latency was defined as the average length of time between the completion of the delay interval and the choice response. The main purpose of this measure was to assess the degree to which drugs affected reaction times. Substantial changes in reaction times can potentially prolong the actual duration of the scheduled delays and may, therefore, cause spurious decreases in accuracy independent of any other alterations in recognition or bias. That is, an overall decrease in accuracy may potentially be the by-product of a drug slowing down reaction times, thereby effectively increasing delays, rather than a more direct result of a drug impairing the attentional or memory components of task performance per se.
Statistical Analysis
The data from all four measures were submitted to repeated measures analyses of variance (ANOVAs) and comparisons of means were conducted using paired t tests. The alpha level used for accepting a statistically significant difference between conditions was p Ͻ .01. Figure 1 shows that, as expected in a short-term recognition memory task such as DMTS, accuracy (measured in terms of percent correct) decreased as delay increased. In each drug condition, as dose increased there was a systematic delay-independent decrease in overall accuracy across delays. Further inspection of the three graphs indicates that there was no greater effect of any given drug or dose at longer delays relative to shorter delays. The patterns demonstrated in Figure 1 are supported by the ANOVA results, which showed a significant effect of delay, Fs(4, 68) ϭ 49.9, 31.8, and 17.2, and drug dose, Fs(3, 51) ϭ 73.6, 40.5, and 53.4, for the MDMA, d-amphetamine, and cocaine conditions, respectively, but no significant interactions between delay and drug dose, Fs(12, 204) ϭ 2.4, 2.0, and 0.9. The doses at which accuracy became noticeably impaired were 2.0, 0.6, and 10.0 mg/kg for MDMA, d-amphetamine, and cocaine, respectively. Although these doses are toward the higher end, they are consistent with the effective dose levels reported previously for rats, pigeons, and monkeys.
Results
A log d and log bias analysis of the data shown in Figure 1 was also conducted to ascertain the extent to which the patterns of accuracy change shown in Figure 1 were the product of changes in discriminability versus response bias. This analysis revealed no significant effect of delay (F Ͻ 1) on bias in any drug condition. Both MDMA and d-amphetamine produced an overall significant effect on response bias, Fs(4, 68) ϭ 10.1 and 4.4, respectively, that emerged only at the highest dose tested under a planned compar-ison analysis that compared each dose with the saline control. Although there was no overall significant effect of cocaine on response bias across all doses, F(4, 68) ϭ 1.7, the planned comparison analysis indicated that bias was significantly greater at the highest dose of cocaine. Therefore, the lower overall performance at the highest dose for MDMA and d-amphetamine shown in Figure 1 partially reflects an increase in response bias (i.e., a tendency to perseverate on a particular choice option across trials). Although response bias contributes to the lower percentage correct values in Figure 1 at the highest doses, an analysis of the data in terms of the bias-free measure log d still revealed exactly the same patterns of change as found with the analysis of percent correct: significant effect of delay, Fs(3, 51) ϭ 94.5, 59.7, and 77.4, and drug dose, Fs(4, 68) ϭ 37.6, 28.7, and 12.3, for MDMA, d-amphetamine, and cocaine conditions, respectively, but no significant interactions between delay and drug dose, F(12, 204) ϭ 2.2, 0.5, and 1.3, on log d. Therefore, in general, the log d and log bias analyses revealed that the decrease in accuracy shown in Figure 1 is best characterized as a decrease in discriminability rather than an increase in response bias, although response bias had an impact at the highest doses. Figure 2 shows the effects of all three drugs on DMTS performance in terms of delay-independent overall levels of accuracy (log d 0 ) and rate of forgetting (b). These values were obtained by fitting the negative exponential model of White (1985) using the method of least squares regression to values of log d for individual subjects in all conditions. In the majority of cases, this model provided an excellent description of the data as reflected by mean squared error values of between 0.015 and 0.032. In 11 of 270 cases, the model failed to provide an adequate description of the data (variance accounted for was less than 75%), and these cases were not included in the subsequent analyses. The lower graph in Figure 2 indicates that for all three drugs there is a tendency for b to decrease between the saline control dose and the middle dose and then to increase to its highest value between the middle and highest doses. However, despite this tendency, one-way ANOVAs revealed that there were no significant changes in b as a function of drug dose, Fs(4, 56) ϭ 0.7, 2.9, and 1.2, for MDMA, d-amphetamine, and cocaine, respectively. In contrast, the top graph in Figure 2 clearly indicates that there is a sizable and systematic decrease in log d 0 between the lowest and highest doses of each drug, Fs(4, 56) ϭ 128.2, 1.8, and 8.5, for MDMA, d-amphetamine, and cocaine, respectively. Therefore, Figure 2 clearly demonstrates that the disruption produced by each drug is best characterized as an overall delay-independent decrease in accuracy rather than an increase in the rate of forgetting as a function of drug dose. Figure 3 shows the influence of responses made on the immediately preceding trial on accuracy in the current trial divided on the basis of whether the response in the preceding trial was the same or different from the responses required in the current trial. All three drugs demonstrated a similar pattern of interaction among drug dose, delay, and the influence of whether the previous response was same or different. ANOVAs conducted for all three drugs separately revealed significant interactions of Previous Response Type ϫ Dose, Fs(4, 68) ϭ 28.1, 14.3, and 8.7 for MDMA, d-amphetamine, and cocaine, respectively, and Previous Response Type ϫ Delay, Fs(4, 68) ϭ 7.8, 16.5, and 8.0 for MDMA, d-amphetamine, and cocaine, respectively. These interactions are reflected in the observation that under saline conditions there is a small but consistent trend for accuracy to be lower on previous response different trials, whereas at medium doses this difference between previous same and previous different trials becomes more pronounced (at the 2.0, 0.3, and 10.0 mg/kg dose for MDMA, d-amphetamine, and cocaine, respectively). Furthermore, at these doses, although the difference in accuracy between previous same and previous different trials remained relatively small at short delays, accuracy on previous different trials was noticeably poorer compared with previous same trials at long delays. This interaction between delay and the effects of previous response type on accuracy was significant at the 2.0 mg/kg dose of MDMA, the 0.3 and 0.6 mg/kg doses of d-amphetamine, and the 3.0 and 10.0 mg/kg doses of cocaine. At the highest dose of each drug, there was a significant main effect of previous response type on accuracy but no interaction of delay and previous response type. In other words, by the highest dose of each drug, current trial performance was very much dictated by the response made on the previous trial irrespective of delay. Across all delays, therefore, rats generally had a correct response rate of 40%-60% on trials that involved making a response that was different from the response made on the preceding trial, whereas they had a 75%-95% correct response rate on trials that required the same response on the current trial as was made on the immediately preceding trial.
Finally, an analysis of response latencies revealed no significant changes across the drugs and doses examined here (all Fs Ͻ 2). Furthermore, a similar analysis in terms of number of trials completed also revealed that there was no significant decrease in number of trials completed in a session as a function of drug dose. These results indicate that the motor components of task performance were not obviously altered by the doses used in the current study with respect to the current task and there were no spurious changes in delay length.
Discussion
A great deal of evidence supports the conclusion that acute administration of various drugs of abuse impairs memory task performance. The current study showed that all three drugs tested here impaired DMTS accuracy in a manner best described as an overall delay-independent decrease in discriminability, a pattern of disruption that has typically been interpreted as reflecting an impairment in encoding or attention (Kirk et al., 1988; White, 1985 White, , 2001 White et al., 1996) . For example, behavioral manipulations that reduce sample salience in a DMTS task (e.g., reducing the time exposed to the initial sample) also reduce overall accuracy (White, 1985) . The current findings are consistent with many previous reports that have shown an overall decrease in accuracy across delays following the administration of d-amphetamine or cocaine (Baron & Wenger, 2001; Baron, Wright & Wenger, 1998; Branch & Dearing, 1982; Bushnell & Levin, 1993; Poling et al., 1992) . What the current study has contributed is a thorough characterization of MDMA's effects on DMTS performance as well as a comparison of all three drugs of abuse within a single study.
Although many drugs and behavioral manipulations produce overall delay-independent decrements in DMTS performance (Dunnett, 1985; Kirk et al., 1988; Harper, 2000; Harper et al., 1994; Ruske et al., 1995; Tan, Kirk, Abraham, & McNaughton, 1989; White & Ruske, 2002) , the three drugs examined in the current study also produced patterns of impairment not previously reported in the drug literature. Specifically, the analysis of proactive interference effects (i.e., the influence of previous response type in terms of same vs. different) revealed two unique patterns with regard to drug effects. First, studies that have examined drugs other than those used here and have analyzed the effects of previous response type (e.g., Dunnett & Martel, 1990; White, Harper & Watson, 1994) have found that the overall decrease in accuracy reported following drug administration is not the product of an increased tendency to be influenced by the response made on the immediately preceding trial. For example, several studies have reported that cholinergic manipulations (Dunnett & Martel, 1990; Harper et al., 1994) produce an overall impairment in DMTS accuracy but do not increase the influence of previous response type. Therefore, although the overall gross pattern of impairment produced by MDMA, d-amphetamine, and cocaine may resemble that seen following cholinergic disruption, the actual cause of the impairment differs. Second, the previous response analysis revealed an interaction between the effects of delay and response type on accuracy. At intermediate doses of all three drugs, the influence of previous response type was greater as delay increased. For example, at 2.0 mg/kg MDMA, there was a relatively small difference in accuracy between previous same and previous different trials at the shortest delays (0.1 and 3.0 s). But at the longest delay (18 s), accuracy was about 80% correct on previous same trials, whereas it was at chance levels on previous different trials (see Figure 3) . In other words, the influence exerted on current trial performance via the response made on the previous trial was much greater at longer delays at doses that produced significant overall impairments in accuracy.
Although not reported previously as a mechanism by which amnesia-producing drugs may exert their disruptive effects on DMTS performance, the present effects of these drugs on proactive interference are akin to the effects of altering the intertrial interval on DMTS performance. For example, a number of studies have shown that decreasing the interval of time between trials increases the impact of previous trial responses on accuracy (Dunnett & Martel, 1990; Edhouse & White, 1988 ). An interpretation of the effect of intertrial interval on previous-trial influence is that the closer trials are together, the more likely subjects are to confuse events in the current trial with those in a previous trial (e.g., Santiago & Wright, 1984) . Therefore, the drug effects reported here may be attenuated in tasks that allow for greater separation between trials (e.g., by arranging for more discriminative stimuli specific to individual trials or by arranging relatively long intertrial intervals).
The proactive interference analysis conducted here allows a more comprehensive picture of the nature of the cognitive impairments produced by MDMA, d-amphetamine, and cocaine. Often the overall delay-independent decrease in accuracy is typically reported as reflecting a problem in effectively attending to or encoding the target stimulus (e.g., see White, 2001 , for a review). However, such an interpretation suggests that previous trial events have very little impact on current trial performance, because such events were never accurately remembered in the first place. The current data do, however, lend themselves to another attentionbased interpretation in terms of an impairment or confusion regarding the overall task structure (i.e., the stable reference memory aspects of task performance). According to this explanation, subjects tended to perform worse as dose increased because they increasingly confused the response made in the choice phase of the previous trial with the sample response in the current trial. At longer delays, this effect was greater because both the current trial sample response and previous trial choice response were relatively distant from the opportunity to make a choice response in the current trial. Thus, although the DMTS task is typically viewed as a working memory paradigm (Ennaceur & Aggleton, 1998; White, 1985; White & Alsop, 1993) , the current pattern of disruption caused by drugs in this study suggests an impairment in performance arising from poor attention or confusion with regard to trial structure. This pattern may reflect an impairment in basic attentional processes in that the rats still "know" what to do (i.e., they still are able to complete trials) and they remember episodic events in each trial (i.e., stimuli presented and responses made), but what they confuse is the sequence of events separating one trial from another.
The impairments in the current study are not a by-product of increased response latencies or nonspecific locomotor disruptions. Measures of these behaviors were not necessarily altered at dose levels that significantly disrupted accuracy. This is an important observation because it helps to rule out several alternate explanations of the pattern of impairment observed. For example, it may have been that any one, or all, of these drugs disrupted motor function (and thus effectively increased delay intervals beyond the length scheduled) or that a drug reduced the relative value of the food reinforcer obtained for correct responding. Both these effects would be quite consistent with the dopamine-releasing effects of all three drugs and previous behavioral studies indicating that such drugs can alter motor activity and reinforcement processes (Beninger, 1983; Beninger et al., 1987; Beninger, Hoffman, & Mazurski, 1989; Green et al., 2003; Ushijima et al., 1995) . In either scenario, it is expected that there would be an overall decrease in accuracy. For example, increasing the response requirement during sampling or reducing relative reinforcer value for correct responses in a DMTS task both reduce overall accuracy across all delays in a DMTS task (McCarthy & Voss, 1995; White, 1985) . However, these possible explanations seem unlikely because either mechanism would also be expected to result in increased response latencies or decreases in number of trials completed; this did not occur.
Note that, although nonsignificant, all three drugs produced a decrease in the rate of forgetting between control and mid-dose levels. This is an interesting trend because of the suggestion made by some authors that stimulant drugs such as d-amphetamine might potentially improve discrimination task performance at relatively low doses by means of a facilitation of attention and vigilance (e.g., Grilly, Gowans, McCann, & Grogan, 1989; Kulig & Calhoun, 1972; Sahgal, 1987) . Although it might be tempting to interpret this trend as providing some level of support for this possibility, the manner in which performance changed is not consistent with the pattern that would actually be expected. Specifically, if these drugs led to an improvement in attentional processes, then a similar pattern of task improvement should emerge, as has been found with manipulations such as increasing the exposure to the initial stimulus (e.g., White, 1985) . These manipulations, however, result in an increase in log d 0 (commonly interpreted as reflecting an increase in attention) rather than the nonsignificant trend of a decrease in b (which would commonly be interpreted as a lower rate of forgetting) found here.
Of relevance to the memory task disruptions caused by drugs of abuse is a consideration of the role played by dopamine activity in the mammalian brain. Consistent with the effects of d-amphetamine, cocaine, and MDMA, systemic injections of dopaminergic agonists (such as the D 2 /D 3 agonist quinpirole) and dopamine antagonists (such as the D 1 agonist SCH23390) and 6-OHDA-induced lesions of dopaminergic pathways in the prefrontal cortex all have been shown to impair working memory task performance (Arnsten, Cai, Murphy, & Goldman-Rakic, 1994; Brozoski, Brown, Rosvold, & Goldman, 1979; Bushnell & Levin, 1993) . Thus, although drugs of abuse such as d-amphetamine, cocaine, and MDMA are associated with a variety of neurochemical changes in brain activity (Bankson & Cunningham, 2002; Green et al., 2003; Mayerhofer, Kovar, & Schmidt, 2001; White et al., 1996; Williams & Goldman-Rakic, 1995) , acutely delivered, these drugs may have their effects on memory primarily because of their disruptive actions on dopamine activity. What the current data suggest is that some of these reported impairments may have been the result of increased confusion between events across separate trials rather than a deficit in the retention of memories. However, confirmation of the role played by dopamine in the current behavioral changes will require a systematic comparison of specific dopamine agonists in terms of their effects on proactive interference in the DMTS and other conditional discrimination tasks.
The role played by dopamine versus 5-HT with respect to the MDMA-induced impairments was not directly tested in the current study, and it may be that an acute increase in the release of 5-HT would also disrupt memory function in the manner found here. However, a specific role of the 5-HT system in memory-based tasks has been questioned. For example, although some reports have found attenuation of lesion-or scopolamine-induced deficits in memory performance following administration of selective 5-HT2 or 5-HT3 antagonists (Domeney et al., 1991; Pitsikas, Brambilla, & Borsini, 1994) , it has not been convincingly demonstrated that these same drugs can improve memory function on their own (Lee, Lin, Chen, & Shin, 1992; Pitsikas et al., 1994) . Similarly, although sufficiently high doses of both specific 5-HT1 agonists and nonspecific 5-HT agonists (such as serotonin reuptake inhibitors) can impair memory task performance, they appear to do so as a result of changes in nonmemorial aspects of the task such as motivation or motor processes (Jansen & Andrews, 1994; Lalonde & Vikis-Freibergs, 1985; Steckler & Sahgal, 1995) .
Finally, it is worth noting that the patterns of impairment observed in the current study are largely consistent with the findings of memory task and attentional deficits in human users currently under the influence of MDMA (e.g., Parrott & Lasky, 1998) as well as reports that attentional processing is impaired in regular heavy users of MDMA (Gouzoulis-Mayfrank et al., 2000; McCann, Mertl, Eligulashvili, & Ricaurte, 1999) . The current experimental data suggest a possible mechanism by which memory task impairments may emerge in MDMA users. Essentially, the memory problems reported may be less a problem with respect to memory per se but more the result of poor attention to task structure, which in turn results in a greater interfering influence from extraneous events in the environment (such as responses and stimuli appearing in previous trials). However, the issue as to whether disruption in attentional processing may be responsible for some of the reported human memory disruption is yet to be specifically examined using a similar approach to that undertaken in the current study.
